![EKRA 101: A Brief Backgrounder and How to Stay Compliant](https://www.g2intelligence.com/wp-content/uploads/2024/05/June24.LIA_.EKRA_Backgrounder_and_Compliance.TC-68716-iStock-525440821-1100x800-1-1080x675.jpg)
EKRA 101: A Brief Backgrounder and How to Stay Compliant
How the Eliminating Kickbacks in Recovery Act of 2018 (EKRA) came to be, what laboratory leaders should know about it, and how to comply
How the Eliminating Kickbacks in Recovery Act of 2018 (EKRA) came to be, what laboratory leaders should know about it, and how to comply
Publishing peer-reviewed studies to tout the economic benefits of medical devices is fairly commonplace, but rare for a laboratory company
Key steps to follow when selling your lab to ensure compliance with the Eliminating Kickbacks in Recovery Act of 2018 (EKRA)
When selling your laboratory, in order to remain compliant with federal code, EKRA is something you will want to consider
Outreach and advertising can be tricky prospects for the clinical lab—but the right questions and strategies can help guide your efforts